Page 3 - சான் ரோகோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சான் ரோகோ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சான் ரோகோ Today - Breaking & Trending Today

Errant Gene Therapeutics Becomes San Rocco Therapeutics


Errant Gene Therapeutics Becomes San Rocco Therapeutics
Errant Gene Therapeutics was founded in 1993, after founder Pat Girondi s son was diagnosed with Thalassemia, a cousin disease to Sickle Cell Anemia.
In 2007, with the help of researchers from Memorial Sloan Kettering, Cornell and National Institute of Health, EGT became the first entity to pass the FDA Recombinant DNA Committee for gene therapy in Sickle Cell Disease and Beta Thalassemia. EGT was the first company to get Orphan Drug Designation for Thalassemia in the US and Europe and first to produce a commercial batch (8-10 patients) of gene therapy for Sickle Cell Disease and Thalassemia. EGT is the company with the longest track record of treating US patients and the only company with experience in both harsh and soft chemotherapeutic prep-regimens. ....

San Rocco , Friuli Venezia Giulia , Patrick Girondi , Pat Girondi , Michel Sadelain , Sloan Kettering , Sam Salman , Lucio Luzzatto , National Institute Of Health , Ethics Committee , Errant Gene Therapeutics , Sickle Cell , Memorial Sloan Kettering , National Institute , Sickle Cell Disease , Orphan Drug Designation , San Rocco Therapeutics , Centro Medico San Rocco , Bluebird Bio , Clonal Dominance , Orphan Disease , சான் ரோகோ , ப்ர்ிஉலி வெனீசியா கியுலியா , ஸ்லோன் கெட்டரிங் , சாம் சல்மான் , தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் ,